Although the TGF-β1 AI did not differ significantly between patients and control individuals, in the context of SLE increased oxidized LDL may promote a low TGF-β1 milieu, permitting excessive cellular apoptosis and enhancing the propensity for atherogenesis. The gene discussed is TGFB1; the disease is systemic lupus erythematosus.